Hanson & Doremus Investment Management decreased its stake in shares of Unilever PLC (NYSE:UL - Free Report) by 46.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,759 shares of the company's stock after selling 7,715 shares during the period. Hanson & Doremus Investment Management's holdings in Unilever were worth $536,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its position in Unilever by 33.2% during the 1st quarter. Bank of New York Mellon Corp now owns 934,804 shares of the company's stock worth $55,668,000 after buying an additional 232,945 shares in the last quarter. Wellington Management Group LLP raised its holdings in Unilever by 13.9% during the 1st quarter. Wellington Management Group LLP now owns 28,100,442 shares of the company's stock worth $1,673,381,000 after purchasing an additional 3,421,054 shares during the last quarter. Stonegate Investment Group LLC raised its holdings in Unilever by 69.7% during the 1st quarter. Stonegate Investment Group LLC now owns 14,282 shares of the company's stock worth $850,000 after purchasing an additional 5,867 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in Unilever by 65.1% during the 1st quarter. Russell Investments Group Ltd. now owns 232,096 shares of the company's stock worth $13,821,000 after purchasing an additional 91,511 shares during the last quarter. Finally, Banco Santander S.A. raised its holdings in Unilever by 70.6% during the 1st quarter. Banco Santander S.A. now owns 15,030 shares of the company's stock worth $895,000 after purchasing an additional 6,220 shares during the last quarter. Institutional investors and hedge funds own 9.67% of the company's stock.
Unilever Price Performance
Shares of UL stock opened at $59.30 on Monday. The stock has a market cap of $145.50 billion, a PE ratio of 16.99, a price-to-earnings-growth ratio of 3.57 and a beta of 0.40. The stock has a 50-day moving average of $61.61 and a 200-day moving average of $61.62. Unilever PLC has a one year low of $54.32 and a one year high of $65.87.
Unilever Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 15th were paid a $0.5175 dividend. This is a boost from Unilever's previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Friday, August 15th. This represents a $2.07 dividend on an annualized basis and a dividend yield of 3.5%. Unilever's dividend payout ratio (DPR) is currently 59.31%.
Wall Street Analyst Weigh In
UL has been the subject of several recent research reports. CICC Research initiated coverage on Unilever in a report on Thursday, August 21st. They set an "outperform" rating for the company. Zacks Research raised Unilever from a "hold" rating to a "strong-buy" rating in a report on Wednesday, September 17th. Finally, Jefferies Financial Group reissued an "underperform" rating on shares of Unilever in a report on Sunday, August 3rd. Three analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Unilever currently has a consensus rating of "Moderate Buy" and a consensus price target of $73.00.
Read Our Latest Report on UL
Unilever Company Profile
(
Free Report)
Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Unilever, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unilever wasn't on the list.
While Unilever currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.